# Real-World Data to Assess the Proportion of Patients Admitted for Febrile Neutropenia That Could Be Considered at Low Risk: The Experience of the Centre Hospitalier Universitaire de Québec

**Authors:** Tommy Jean, Camille Sylvestre, Francis Caron, Dominique Leblanc, Geneviève Soucy, Julie Lemieux

PMC · DOI: 10.3390/curroncol32030133 · Current Oncology · 2025-02-26

## TL;DR

This study found that over half of patients hospitalized for febrile neutropenia could be considered low-risk and might safely be treated as outpatients.

## Contribution

The study provides real-world data on the proportion of hospitalized febrile neutropenia patients who meet low-risk outpatient criteria.

## Key findings

- 57.1% of hospitalized patients met low-risk febrile neutropenia criteria based on MASCC scores.
- 41.8% of patients met all criteria for outpatient treatment and had a 94.6% favorable outcome rate.
- 44.7% of patients not eligible for outpatient treatment still had favorable outcomes during hospitalization.

## Abstract

Febrile neutropenia (FN) is a serious complication of chemotherapy that often leads to hospitalization in cancer patients. It is now well-established that carefully selected patients can be safely treated on an outpatient basis. The objective of this study was to assess the number and proportion of patients hospitalized for FN in a university hospital setting who would have met the low-risk criteria for FN, and whether these patients experienced favorable outcomes during hospitalization. We conducted a retrospective study of all patients admitted for FN at three hospitals in Quebec City between 1 January 2018 and 31 December 2019. Patients with leukemia and those who had undergone stem cell transplants were excluded. A retrospective chart review was performed to establish the Multinational Association for Supportive Care in Cancer (MASCC) score for each patient. Based on predefined criteria, we also determined whether the clinical course was favorable or unfavorable. A total of 177 hospitalizations met our inclusion criteria. We found that 101/177 (57.1%) of the hospitalized patients met the low-risk FN criteria according to their MASCC score. Among these, 74/177 (41.8%) met all the criteria for outpatient treatment. The majority of these patients had a favorable outcome (70/74, 94.6%). In contrast, among patients who did not meet the eligibility criteria for outpatient treatment, 44.7% (46/103) experienced favorable outcomes during their hospitalization. These data highlight the importance of patient selection for outpatient care.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** Cancer (MESH:D009369), FN (MESH:D064147), leukemia (MESH:D007938)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11941422/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11941422/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC11941422/full.md

---
Source: https://tomesphere.com/paper/PMC11941422